FI922551A0 - Foerfarande foer skoetsel av septisk chock. - Google Patents

Foerfarande foer skoetsel av septisk chock.

Info

Publication number
FI922551A0
FI922551A0 FI922551A FI922551A FI922551A0 FI 922551 A0 FI922551 A0 FI 922551A0 FI 922551 A FI922551 A FI 922551A FI 922551 A FI922551 A FI 922551A FI 922551 A0 FI922551 A0 FI 922551A0
Authority
FI
Finland
Prior art keywords
skoetsel
septisk
chock
foerfarande foer
antagonist
Prior art date
Application number
FI922551A
Other languages
English (en)
Other versions
FI922551A (fi
Inventor
H Fletcher Starnes
John S Abrams
Original Assignee
Schering Corp
H Fletcher Starnes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp, H Fletcher Starnes filed Critical Schering Corp
Publication of FI922551A0 publication Critical patent/FI922551A0/fi
Publication of FI922551A publication Critical patent/FI922551A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244Interleukins [IL]
    • C07K16/248IL-6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fertilizers (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Compression-Type Refrigeration Machines With Reversible Cycles (AREA)
  • Spinning Or Twisting Of Yarns (AREA)
  • Treatment Of Sludge (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI922551A 1989-12-04 1992-06-03 Foerfarande foer skoetsel av septisk chock. FI922551A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44519289A 1989-12-04 1989-12-04
PCT/US1990/006872 WO1991007986A1 (en) 1989-12-04 1990-11-30 Method of treating septic shock

Publications (2)

Publication Number Publication Date
FI922551A0 true FI922551A0 (fi) 1992-06-03
FI922551A FI922551A (fi) 1992-06-03

Family

ID=23767939

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922551A FI922551A (fi) 1989-12-04 1992-06-03 Foerfarande foer skoetsel av septisk chock.

Country Status (11)

Country Link
EP (1) EP0504307B1 (fi)
JP (1) JPH0747547B2 (fi)
AT (1) ATE100331T1 (fi)
AU (1) AU648777B2 (fi)
CA (1) CA2070424A1 (fi)
DE (1) DE69006221T2 (fi)
DK (1) DK0504307T3 (fi)
ES (1) ES2062762T3 (fi)
FI (1) FI922551A (fi)
HU (1) HUT64481A (fi)
WO (1) WO1991007986A1 (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0672144A1 (en) * 1992-10-20 1995-09-20 Chiron Corporation Interleukin-6 receptor antagonists
JP3525221B2 (ja) * 1993-02-17 2004-05-10 味の素株式会社 免疫抑制剤
ES2108460T3 (es) * 1993-06-03 1997-12-16 Therapeutic Antibodies Inc Fragmentos de anticuerpos en terapeutica.
DE4409513C1 (de) * 1994-02-07 1995-10-19 Knoll Ag Verwendung von anti-TNF-Antikörpern als Arzneimittel zur Behandlung von Erkrankungen mit einem erhöhten Interleukin-6 Serumspiegel
US8017121B2 (en) 1994-06-30 2011-09-13 Chugai Seiyaku Kabushika Kaisha Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
PT783893E (pt) * 1994-10-07 2012-05-24 Chugai Pharmaceutical Co Ltd Inibição do crescimento anormal das células sinoviais usando antagonistas de il-6 como componente ativo
AU730308B2 (en) * 1997-06-18 2001-03-01 Rockefeller University, The Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof
US8034344B2 (en) 2008-05-13 2011-10-11 Novimmune S.A. Anti-IL-6/IL-6R antibodies and methods of use thereof
US8188235B2 (en) 2008-06-18 2012-05-29 Pfizer Inc. Antibodies to IL-6 and their uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2598666B2 (ja) * 1987-10-19 1997-04-09 忠三 岸本 抗ヒトbcdfモノクローナル抗体
CA1341588C (en) * 1988-01-26 2009-01-06 Michel Revel Human ifn-beta2/i1-6, its purification and use
ES2058490T3 (es) * 1988-02-02 1994-11-01 Schering Biotech Corp Metodo de reducir respuestas de inmunoglobulina e.
EP0399429A1 (en) * 1989-05-22 1990-11-28 Toray Industries, Inc. Anti-human interleukin-6 monoclonal antibody

Also Published As

Publication number Publication date
DE69006221D1 (de) 1994-03-03
ES2062762T3 (es) 1994-12-16
CA2070424A1 (en) 1991-06-05
WO1991007986A8 (en) 2004-04-22
JPH0747547B2 (ja) 1995-05-24
HUT64481A (en) 1994-01-28
EP0504307B1 (en) 1994-01-19
ATE100331T1 (de) 1994-02-15
AU648777B2 (en) 1994-05-05
FI922551A (fi) 1992-06-03
EP0504307A1 (en) 1992-09-23
DK0504307T3 (da) 1994-03-21
DE69006221T2 (de) 1994-05-05
AU7179491A (en) 1991-06-26
WO1991007986A1 (en) 1991-06-13
JPH05504058A (ja) 1993-07-01
HU9201859D0 (en) 1992-09-28

Similar Documents

Publication Publication Date Title
UA111707C2 (uk) Застосування виділеного анти-tnf-альфа антитіла людини
MY107079A (en) Method of reducing immunoglobulin e responses
DE3684211D1 (fi)
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
FI922551A (fi) Foerfarande foer skoetsel av septisk chock.
EA200400930A1 (ru) Блокирующее моноклональное антитело к vla-1 или его применение для лечения воспалительных заболеваний
MY107386A (en) Method of preventing or reducing eosinophilia
WO1996040041A3 (en) Antibodies to fas antigen capable of inhibiting apoptosis
FI924278A0 (fi) Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner.

Legal Events

Date Code Title Description
FD Application lapsed